20250215438. Immune Cells Having (Arsenal Biosciences, .)
IMMUNE CELLS HAVING CO-EXPRESSED TGFBR SHRNAS
Abstract: provided herein are recombinant nucleic acids that reduce expression of tgfbr1 and/or tgfbr2 and cells comprising such recombinant nucleic acids. also provided are methods of making and using such cells.
Inventor(s): John Gagnon, Adam Litterman, Amy-Jo Casbon, Brenal Singh, Jason Hall, Natalie Bezman, Aaron Cooper, Levi Gray-Rupp
CPC Classification: C12N15/1138 ({against receptors or cell surface proteins})
Search for rejections for patent application number 20250215438
Categories:
- Patent Applications
- Arsenal Biosciences, Inc.
- CPC C12N15/1138
- John Gagnon of San Francisco CA US
- Adam Litterman of San Francisco CA US
- Amy-Jo Casbon of San Francisco CA US
- Brenal Singh of San Francisco CA US
- Jason Hall of South San Francisco CA US
- Natalie Bezman of Foster City CA US
- Aaron Cooper of Berkeley CA US
- Levi Gray-Rupp of Philadelphia PA US